Pepsin in nonacidic refluxate can damage hypopharyngeal epithelial cells
- PMID: 19810610
- DOI: 10.1177/000348940911800913
Pepsin in nonacidic refluxate can damage hypopharyngeal epithelial cells
Abstract
Objectives: Studies using combined multichannel intraluminal impedance with pH monitoring reveal a role for nonacidic reflux in laryngopharyngeal symptoms and injury. We have discovered that pepsin is taken up by laryngeal epithelial cells by receptor-mediated endocytosis. This finding reveals a novel mechanism by which pepsin could cause cell damage, potentially even in nonacidic refluxate. The objective of this study was to determine whether pepsin, at pH 7.4 and thus in nonacidic refluxate, causes cell damage.
Methods: Cultured hypopharyngeal epithelial (FaDu) cells were exposed to human pepsin (0.1 mg/mL) at pH 7.4 for either 1 hour or 12 hours at 37 degrees C and analyzed by electron microscopy, cytotoxicity assay, and SuperArray.
Results: We report mitochondrial and Golgi complex damage in cells exposed to pepsin at neutral pH, observed by electron microscopy. We also report cell toxicity of pepsin at pH 7.4, measured by a cytotoxicity assay. Furthermore, using SuperArray, we found that pepsin at pH 7.4 significantly alters the expression levels of multiple genes implicated in stress and toxicity.
Conclusions: These findings are perhaps the first to explain why many patients have symptoms and injury associated with nonacidic reflux, and could have important implications for the development of new therapies for reflux, such as pepsin receptor antagonists and/or irreversible inhibitors of peptic activity.
Similar articles
-
Rationale for targeting pepsin in the treatment of reflux disease.Ann Otol Rhinol Laryngol. 2010 Aug;119(8):547-58. doi: 10.1177/000348941011900808. Ann Otol Rhinol Laryngol. 2010. PMID: 20860281
-
Pepsin as a causal agent of inflammation during nonacidic reflux.Otolaryngol Head Neck Surg. 2009 Nov;141(5):559-63. doi: 10.1016/j.otohns.2009.08.022. Otolaryngol Head Neck Surg. 2009. PMID: 19861190
-
Receptor-mediated uptake of pepsin by laryngeal epithelial cells.Ann Otol Rhinol Laryngol. 2007 Dec;116(12):934-8. doi: 10.1177/000348940711601211. Ann Otol Rhinol Laryngol. 2007. PMID: 18217514
-
Pepsin in gastroesophageal and extraesophageal reflux: molecular pathophysiology and diagnostic utility.Curr Opin Otolaryngol Head Neck Surg. 2020 Dec;28(6):401-409. doi: 10.1097/MOO.0000000000000664. Curr Opin Otolaryngol Head Neck Surg. 2020. PMID: 33060393 Review.
-
New techniques in measuring nonacidic esophageal reflux.Semin Thorac Cardiovasc Surg. 2001 Jul;13(3):255-64. doi: 10.1053/stcs.2001.25312. Semin Thorac Cardiovasc Surg. 2001. PMID: 11568871 Review.
Cited by
-
How to Approach Laryngopharyngeal Reflux: An Otolaryngology Perspective.Curr Gastroenterol Rep. 2016 Aug;18(8):44. doi: 10.1007/s11894-016-0515-z. Curr Gastroenterol Rep. 2016. PMID: 27417389 Review.
-
The patient with sore throat.Med Clin North Am. 2010 Sep;94(5):923-43. doi: 10.1016/j.mcna.2010.06.001. Med Clin North Am. 2010. PMID: 20736104 Free PMC article. Review.
-
Analysis of Esophageal Motility and Reflux Characteristics in Patients with Gastroesophageal Reflux Disease With or Without Extraesophageal Symptoms.Turk J Gastroenterol. 2022 Apr;33(4):280-285. doi: 10.5152/tjg.2022.201040. Turk J Gastroenterol. 2022. PMID: 35550536 Free PMC article.
-
Pepsin promotes IL-8 signaling-induced epithelial-mesenchymal transition in laryngeal carcinoma.Cancer Cell Int. 2019 Mar 20;19:64. doi: 10.1186/s12935-019-0772-7. eCollection 2019. Cancer Cell Int. 2019. PMID: 30936780 Free PMC article.
-
Swallowing disorders after treatment for head and neck cancer.Radiol Oncol. 2019 Jun 1;53(2):225-230. doi: 10.2478/raon-2019-0028. Radiol Oncol. 2019. PMID: 31194691 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical